Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Diane Descamps and Benoit Visseaux.
Connection Strength

4.338
  1. Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2. Viruses. 2021 08 19; 13(8).
    View in: PubMed
    Score: 0.241
  2. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection. J Infect Dis. 2021 05 20; 223(9):1522-1527.
    View in: PubMed
    Score: 0.237
  3. Performance evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel. Int J Infect Dis. 2021 Jun; 107:179-181.
    View in: PubMed
    Score: 0.235
  4. Viral epidemiology and SARS-CoV-2 co-infections with other respiratory viruses during the first COVID-19 wave in Paris, France. Influenza Other Respir Viruses. 2021 07; 15(4):425-428.
    View in: PubMed
    Score: 0.235
  5. Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements. J Virol Methods. 2021 05; 291:114086.
    View in: PubMed
    Score: 0.232
  6. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the First Rapid Multiplex PCR Commercial Assay for SARS-CoV-2 Detection. J Clin Microbiol. 2020 Jul 23; 58(8).
    View in: PubMed
    Score: 0.223
  7. Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection. J Clin Virol. 2020 08; 129:104520.
    View in: PubMed
    Score: 0.222
  8. Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence? J Antimicrob Chemother. 2020 01 01; 75(1):183-193.
    View in: PubMed
    Score: 0.215
  9. HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man. Open Forum Infect Dis. 2018 Oct; 5(10):ofy223.
    View in: PubMed
    Score: 0.196
  10. Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads. J Virol Methods. 2018 07; 257:12-15.
    View in: PubMed
    Score: 0.190
  11. Corrigendum to "HIV-2 molecular epidemiology" [Infect. Genet. Evol. 46 (2016) 233-240]. Infect Genet Evol. 2018 03; 58:294.
    View in: PubMed
    Score: 0.187
  12. Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016. PLoS One. 2017; 12(7):e0180888.
    View in: PubMed
    Score: 0.181
  13. Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study. J Clin Virol. 2017 06; 91:52-57.
    View in: PubMed
    Score: 0.178
  14. Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study. PLoS One. 2017; 12(2):e0172809.
    View in: PubMed
    Score: 0.176
  15. The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. 2021 10; 83(4):e1-e3.
    View in: PubMed
    Score: 0.060
  16. High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings. J Clin Virol. 2021 08; 141:104895.
    View in: PubMed
    Score: 0.060
  17. The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients. J Infect. 2021 Jul; 83(1):119-145.
    View in: PubMed
    Score: 0.059
  18. Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity. Nat Immunol. 2021 03; 22(3):322-335.
    View in: PubMed
    Score: 0.058
  19. Correction: Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department. PLoS One. 2021; 16(1):e0246458.
    View in: PubMed
    Score: 0.058
  20. Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study. PLoS One. 2020; 15(12):e0243961.
    View in: PubMed
    Score: 0.057
  21. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives. Clin Microbiol Infect. 2020 12 08.
    View in: PubMed
    Score: 0.057
  22. Characteristics associated with COVID-19 or other respiratory viruses' infections at a single-center emergency department. PLoS One. 2020; 15(12):e0243261.
    View in: PubMed
    Score: 0.057
  23. Reply to Yan and Muller, "Captisol and GS-704277, but Not GS-441524, Are Credible Mediators of Remdesivir's Nephrotoxicity". Antimicrob Agents Chemother. 2020 11 17; 64(12).
    View in: PubMed
    Score: 0.057
  24. Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19. Antimicrob Agents Chemother. 2020 10 20; 64(11).
    View in: PubMed
    Score: 0.057
  25. Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott). J Clin Virol. 2020 11; 132:104618.
    View in: PubMed
    Score: 0.056
  26. Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. J Antimicrob Chemother. 2020 09 01; 75(9):2657-2660.
    View in: PubMed
    Score: 0.056
  27. Failure of hydroxychloroquine pre-exposure prophylaxis in COVID-19 infection? A case report. J Antimicrob Chemother. 2020 09 01; 75(9):2706-2707.
    View in: PubMed
    Score: 0.056
  28. Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2. J Clin Virol. 2020 Sep; 130:104573.
    View in: PubMed
    Score: 0.056
  29. New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017. Euro Surveill. 2019 Sep; 24(39).
    View in: PubMed
    Score: 0.053
  30. HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen. J Antimicrob Chemother. 2019 06 01; 74(6):1679-1692.
    View in: PubMed
    Score: 0.052
  31. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France. J Antimicrob Chemother. 2019 05 01; 74(5):1417-1424.
    View in: PubMed
    Score: 0.051
  32. Characterizing the structural variability of HIV-2 protease upon the binding of diverse ligands using a structural alphabet approach. J Biomol Struct Dyn. 2019 10; 37(17):4658-4670.
    View in: PubMed
    Score: 0.050
  33. Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58. J Infect Dis. 2018 08 24; 218(7):1027-1036.
    View in: PubMed
    Score: 0.049
  34. Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants. PLoS One. 2018; 13(6):e0198334.
    View in: PubMed
    Score: 0.048
  35. Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients. J Antimicrob Chemother. 2018 05 01; 73(5):1173-1176.
    View in: PubMed
    Score: 0.048
  36. Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases. Sci Rep. 2018 04 10; 8(1):5789.
    View in: PubMed
    Score: 0.048
  37. Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet. Sci Rep. 2018 01 15; 8(1):710.
    View in: PubMed
    Score: 0.047
  38. No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir. J Antimicrob Chemother. 2018 Jan 01; 73(1):173-176.
    View in: PubMed
    Score: 0.047
  39. Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients. J Antimicrob Chemother. 2017 10 01; 72(10):2954-2955.
    View in: PubMed
    Score: 0.046
  40. Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. J Antimicrob Chemother. 2017 06 01; 72(6):1745-1751.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.